Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant—review article Reham AlghandourDoaa H. SakrYasmin Shaaban Review Article Open access 02 May 2023 Pages: 1287 - 1300
Ofatumumab regimens in chronic lymphocytic leukemia: a meta-analysis Muhammad Hossein AshoubAmirreza NaseriMasoud Mohammadi Review Article 03 May 2023 Pages: 1301 - 1306
Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement Mohammad SayyadiSaeed HassaniAkbar Dorgalaleh Review Article 19 April 2023 Pages: 1307 - 1322
Heme oxygenase 1 in erythropoiesis: an important regulator beyond catalyzing heme catabolism Rui LiuXuzhi ZhangHuiyong Chen Review Article 12 April 2023 Pages: 1323 - 1332
A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia Siddhibhong JongkraijakraThitima DoungngernArnuparp Lekhakula Original Article 03 April 2023 Pages: 1333 - 1340
An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial Maria TsilikaJohn MitrouEvangelos J. Giamarellos-Bourboulis Original Article Open access 06 April 2023 Pages: 1341 - 1349
Association between vitamin D status and eryptosis–results from the German National Cohort Study Franz EwendtMarvin SchmittGabriele I. Stangl Original Article Open access 01 May 2023 Pages: 1351 - 1361
Pseudothrombocytopenia, beyond a laboratory phenomenon: study of 192 cases Núria Pujol-MoixEduardo Muñiz-DíazJuan Carlos Souto Original Article 31 March 2023 Pages: 1363 - 1374
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials Luigia LucianoRoberto LatagliataMassimo Breccia Original Article Open access 20 April 2023 Pages: 1375 - 1382
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission – a multi-center study Christophe DesprezAchille KouatchetCorentin Orvain Original Article 11 April 2023 Pages: 1383 - 1393
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects Inge G.P. GeelenStein-Erik GullaksenJeroen J.W.M. Janssen Original Article 29 April 2023 Pages: 1395 - 1408
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort Daniele CattaneoCristina BucelliAlessandra Iurlo Original Article 20 April 2023 Pages: 1409 - 1420
Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma Takashi IshioShihori TsukamotoTakeshi Kondo Original Article Open access 12 April 2023 Pages: 1421 - 1431
The prognostic value of controlling nutritional status (CONUT) score–based nomogram on extranodal natural killer/T cell lymphoma patients Shuo ZhangCai SunWei Sang Original Article 19 April 2023 Pages: 1433 - 1442
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis Kimberley DoucetteAllison O. TaylorCatherine Lai Original Article 24 April 2023 Pages: 1443 - 1458
The presence of two light chain bands on immunofixation is associated with poor outcomes in newly diagnosed multiple myeloma patients Ameni JerbiOmar TurkiHatem Masmoudi Original Article 15 April 2023 Pages: 1459 - 1466
Clinical outcomes after incomplete cycles of R-CHOP for diffuse large B-cell lymphoma: 10 years’ real-world experience in a single institute Jeesun YoonKi Hwan KimJin Hyun Park Original Article 26 April 2023 Pages: 1467 - 1476
Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment Taku KikuchiNobuhiro TsukadaTadao Ishida Original Article 28 April 2023 Pages: 1477 - 1483
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma Yu YagiYusuke KanemasaTatsu Shimoyama Original Article 28 April 2023 Pages: 1485 - 1500
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis Martin StorkIvan SpickaLudek Pour Original Article Open access 24 April 2023 Pages: 1501 - 1511
Risk–benefit ratio of percutaneous kyphoplasty and percutaneous vertebroplasty in patients with newly diagnosed multiple myeloma with vertebral fracture: a single-center retrospective study Qiu-Qing XiangBin ChuLi Bao Original Article Open access 30 March 2023 Pages: 1513 - 1522
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells Xia XiongYibing YuMingfeng Zhao Original Article 22 April 2023 Pages: 1523 - 1535
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation Muzaffer KeklikBurak DeveciOlcay Y. Jones Original Article 17 April 2023 Pages: 1537 - 1547
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics Satoshi YamasakiShohei MizunoMasamitsu Yanada Original Article 01 May 2023 Pages: 1549 - 1559
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide Ignacio Gómez-CenturiónReyes Maria Martin RojasMi Kwon Original Article 21 April 2023 Pages: 1561 - 1567
Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme Lu WangPeiyan KongXi Zhang Original Article Open access 25 April 2023 Pages: 1569 - 1579
Brazilian experience with caplacizumab in acquired thrombotic thrombocytopenic purpura: outcomes of the expanded access program Tiago de Oliveira BoechatJoão Samuel de Holanda FariasMichaela Larissa Lobo de Andrade Original Article 13 April 2023 Pages: 1581 - 1588
Gut microbiome alterations in patients with COVID-19-related coagulopathy Youli ChenXin LiXiaohua Hou Original Article 11 April 2023 Pages: 1589 - 1598
Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient Süreyya Yiğit KayaSebnem BektasÖmür Gökmen Sevindik Letter to the Editor 26 April 2023 Pages: 1599 - 1600
T-cell lymphoma associated with dupilumab Mitsuhiro ShimadaShojiro InanoToshiyuki Kitano Letter to the Editor 27 April 2023 Pages: 1601 - 1602
Meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data Andrea MessoriGiulia Hyeraci Letter to the Editor 06 March 2023 Pages: 1603 - 1605
Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic Luca GuarneraElisa BuzzattiMaria Ilaria Del Principe Letter to the Editor 25 March 2023 Pages: 1607 - 1608
Staphylococcus intermedius infection with splenic abscesses in a patient with acute lymphoblastic leukemia Lisa HauptmannDanica MidicUlf Schnetzke Letter to the Editor Open access 04 April 2023 Pages: 1609 - 1611
Aleukemic mast cell leukemia, well-differentiated and chronic type Kenneth ChenPaul C. HendrieKikkeri N. Naresh Letter to the Editor 04 April 2023 Pages: 1613 - 1615
Evidence of bendamustine plus rituximab for old and frail patients with aggressive B-cell lymphoma Enrico SchalkKathleen Jentsch-Ullrich Letter to the Editor Open access 16 March 2023 Pages: 1617 - 1620
Hematopoietic cell transplantation for congenital dyserythropoietic anemia IV caused by compound heterozygous KLF1 mutations Kun YangWeiye NieXiaolin Yin Letter to the Editor 31 March 2023 Pages: 1621 - 1624
Solitary follicular lymphoma with plasmacytic differentiation associated with localized AL amyloidosis in the jejunum Katsushi TajimaTakashi NomuraHironobu Naiki Letter to the Editor 05 April 2023 Pages: 1625 - 1627
